Announcements Trials
Browse Landscape

Phase

Phase NA 16Phase 4 3Phase 2 2Phase 1 2Phase 3 1Phase 1/2 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Dermatologic 3Thoracic 2Breast 2Other hematologic neoplasm 1

Conditions

Melanoma 3Neoplasms 1Lung Neoplasms 1

Interventions

Imiquimod 15Aminolevulinic Acid 8Fluorouracil 6Diclofenac 63-ingenyl angelate 6Nivolumab 5Cryotherapy 5tirbanibulin 4methyl 5-aminolevulinate 4Sirolimus 4denileukin diftitox 3aldesleukin 3Photochemotherapy 3Ipilimumab 3Blood Specimen Collection 3relatlimab 2Vemurafenib 2Tacrolimus 2Prednisone 2Ointments 2Methotrexate 2Immune Checkpoint Inhibitors 2HhAntag691 2Gels 2Cyclosporine 2Cryosurgery 2trametinib 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1technetium Tc 99m nanocolloid 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Blood Specimen Collection × Dermatologic × Clear all
NCT02626065 2025-09-15

PAIR

Hospices Civils de Lyon

Phase 4 Completed
32 enrolled
Dermatologic

Melanoma

NCT03313544 2023-04-21

Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1

Assistance Publique Hopitaux De Marseille

Phase 4 Unknown
50 enrolled
DermatologicThoracic

Lung Neoplasms, Melanoma

NCT02068196 2023-03-24

Ipi4

Oslo University Hospital

Phase 4 Active not recruiting
150 enrolled
Dermatologic

Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡